Showing posts with label Repair. Show all posts
Showing posts with label Repair. Show all posts

Friday, August 4, 2017

How Injured Nerve Cells Can Repair Themselves


Today's easy to read and interesting post from news-medical.net (see link below) talks about how nerve cells can and do regenerate and how certain molecules make that happen. Researchers are trying to find ways to speed up that process, with obvious benefits for neuropathy patients, especially those with axonal neuropathy where the damage can be some distance from the nerve nucleus. It's one more example of how research at a molecular level may be of great benefit in the future.


Researchers study how nerve cells repair themselves after injury
Posted in: Medical Science News | Medical Research News
Published on March 25, 2013 at 3:22 AM ·


One molecule makes nerve cells grow longer. Another one makes them grow branches. These new experimental manipulations have taken researchers a step closer to understanding how nerve cells are repaired at their farthest reaches after injury. The research was recently published in the Journal of Neuroscience.

"If you injure a peripheral nerve, it will spontaneously regenerate, but it goes very slowly. We're trying to speed that up," said Dr. Jeffery Twiss, a professor and head of the biology department at Drexel University in the College of Arts and Sciences, who was senior author of the paper.

But, Twiss said, scientists still have a lot to learn about how nerve cells repair themselves. He and his colleagues are especially interested in how nerve cells are repaired in their longest-reaching sections, their axons. Axons can be up to a meter long in adult human nerve cells, extending away from the cell body toward neighboring nerve cells, with which they exchange signals. Restoring length to damaged axons is essential to restoring nerve function, but coordinating these repairs at a great distance from the cell's nucleus involves a mix of complex processes within each cell. To gain insight into these processes, they have focused research, including the present study, on repair proteins that are created locally near an injury site in a nerve's axon.

Dr. Christopher Donnelly, now a postdoctoral fellow at Johns Hopkins University, led the study as part of his dissertation work in Twiss' lab while at the University of Delaware.

Donnelly and Twiss knew from their previous research that two of the messenger RNA(mRNA) molecules involved in directing repair in injured axons compete against each other at an essential step in repairing damage. The mRNA molecules that "win" the competition get to make their particular repair-protein product.

So, experimentally, they rigged the competition between those molecules to see what would happen. Could one molecule make a difference in helping axons grow longer, faster?

The technical process of these experiments was complex, but the answers are easy to see.

They saw more branches in the axons when they added more mRNA used to make the repair protein beta-actin, while taking away the mRNA for the protein GAP-43.

But they got the desired longer, less-branched axons from the opposite experiment, adding mRNA coding for GAP-43 and taking away that for beta-actin.

This was a promising result for developing potential therapies, Donnelly said. When nerves repair themselves after injury, there is currently no way to control their pattern of regrowth. But, "if you can induce longer growth quicker, rather than branching growth, you can help reach the target of faster recovery from an injury."

Yet other modifications, selectively withholding the mRNA molecules, resulted in shorter axons, or in fewer axon branches - and the researchers found they could experimentally and selectively restore branching or lengthening growth in those deprived cells, too. Consistent with the first experiments' results, adding more beta-actin mRNA again restored axon branching, and adding more GAP-43 mRNA again restored axon length.

But a key point in these experiments is that all of the changes only happened when they added mRNA molecules that functioned as the proteins' "local recipe" used especially for making these proteins in the nerves' axons. The "standard recipe" of mRNA, that directs cells to make those same proteins in the cell body, didn't have these distinct effects on the axons' growth.

This experimental technique to manipulate axon growth was not previously tested, the authors noted. They found most of these results using adult rat neurons in vitro, but also confirmed the principles in vivo with the developing spinal cord of chicken embryos in collaboration with Dr. Gianluca Gallo of Temple University.

"This sets some of the groundwork needed to consider using these mechanisms for improving regeneration in the future," Twiss said. This basic science research will require further testing in animals before considering any advance to humans as an eventual possibility. Drexel University has filed a patent application for the techniques used in these experiments to selectively drive translation of mRNA molecules of interest within axons.

Source: Drexel University

http://www.news-medical.net/news/20130325/Researchers-study-how-nerve-cells-repair-themselves-after-injury.aspx

Thursday, June 1, 2017

Lasers May Be Able To Repair Damaged Nerve Sheaths


Today's post from diabetesqld.org (see link below) is an article from an Australian website that reports on what could be the next big thing regarding neuropathy treatment. I know...I can hear you sighing...after so many 'next big things' that turn out to be false dawns, we tend to view new findings with some skepticism don't we? However, the science behind this one seems to be solid and although many more studies are needed (as always), the idea that non-invasive laser treatment may be able to repair damaged myelin sheaths (insulation around the nerves) is a very attractive one. Also encouraging; the Brazilian lab admits it doesn't know why this seems to work but they have some theories that time will either prove or disprove. It may be a question from a dumb onlooker but precisely where do you apply the laser treatment? The very nature of peripheral neuropathy means that the damaged nerves can be very hard to pin down and identify. Just because the pain is in the feet or hands, doesn't mean that the damage is there also. I guess we'll just have to wait and see but this is one of those research discoveries you hope will turn out to be true and workable for us long-term sufferers.

Neuropathic pain? Science says lasers can help.
31 March 2017 /


 Recent studies at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil shows low-level laser therapy to be a non-invasive and effective alternative for treating neuropathic pain, a chronic condition caused by nerve damage, spinal cord injury or diseases such as diabetes.

The treatment in a model of diabetic neuropathy, one of the most common chronic and incapacitating complications of diabetes, was tested. Neuropathic pain in diabetes occurs when the disease is not properly controlled and excessive amounts of blood sugar cause oxidation of the myelin sheath, damaging the structure of peripheral nerves. As well as causing pain, this degenerative process impairs communication among neurons and can even lead to amputation of the lower limbs.

"We tested laser therapy in different rat neuropathy models, and behavioral responses improved in all of them," Professor Marucia Chacur, the principal investigator, said. "One of the beneficial effects observed was myelin sheath recovery. The myelin sheath is a lipid layer that covers the axon and acts as electrical insulation to assist nerve impulse propagation."

With the aid of a transmission electron microscope, the researchers found that as diabetes progressed, the structure of the sciatic nerve's myelin sheath changed. After four sessions of the treatment, however, the myelin had almost completely recovered.

"The condition of the nerve practically returned to baseline levels after treatment. We're now continuing the study by analyzing protein expression and the release of inflammatory cytokines to understand exactly what's happening," Chacur said.

In a second study, treatment focused on the sciatic nerve, and found that astrocytes - star-shaped cells that play an active role in brain function and inflammatory responses - were the first type of cell to migrate to the site of a nerve injury or inflammatory process. These cells release several inflammatory mediators, which in turn trigger the release of other inflammatory substances.

"We believe the laser curtails this chain reaction as if it were anti-inflammatory medication, by reducing the migration of astrocytes to the site of the injury," Chacur said.

The third model used to test low-level laser therapy focused on orofacial pain, involving the inferior alveolar nerve, one of the branches of the trigeminal nerve responsible for innervating the face. Phototherapy started two days after injury and improvement was observed after two sessions.

"We set out to understand the mechanisms and mediators involved because we believed phototherapy could be used in association with pharmacological treatment because it acts via a different pathway. In this way, it may be possible to reduce the drug dose and mitigate the systemic effects of the treatment," Chacur said.

The results suggest that all three models of neuropathic pain studied share a common mechanism involving myelin sheath regeneration and reduced astrocyte migration to the site of the lesion, she added.

"Evidence in the literature also suggests an effect on mitochondria. The laser apparently facilitates the flow of calcium in these organelles, boosting production of ATP [adenosine triphosphate, the body's cellular fuel] and leading to enhanced healing as well as the release of mediators that assist remodeling. In future studies, we plan to investigate this effect on mitochondria more thoroughly," Chacur concluded.

http://www.diabetesqld.org.au/media-centre/2017/march/neuropathic-pain-science-says-lasers-can-help.aspx